HALEOSLABSBSEHaleos Labs LtdHighNeutral
Announced Fri, 1 May · 01:34 IST

Outcome along with Scrutinizers report.

Strategic Transactions View source PDF

HALEOSLABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.8%1-day move
₹1473.10
prior close
₹1499.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.4+1.4+0.0+0.3+0.8+8.6+9.6+13.7+8.8+6.0+11.3-5.0+10.3
Up moveDown movePending
AI summary

Haleos Labs Limited conducted a Postal Ballot to seek shareholder approval for issuing a corporate guarantee to RBL Bank. The guarantee secures external commercial borrowings taken by Mahi Drugs Private Limited, which is a material subsidiary of the company. The resolution was passed as an Ordinary Resolution with 99.99% votes in favour (1,05,592 votes) and only 8 votes against. Notably, the Promoter and Promoter Group, who hold 21,79,976 shares, did not participate in the voting due to their interest in the matter. The resolution was deemed passed on April 29, 2026, with low participation from public non-institutional shareholders at only 11.59% turnout.

Likely market impact

This approval allows the company to support its subsidiary's borrowing through a guarantee, which could increase financial exposure for Haleos Labs shareholders. The near-unanimous vote signals shareholder confidence, though the lack of promoter voting warrants attention as it indicates related party involvement.